Skip to content

Medical records based retrospective analysis of cut-off value of platelet intervention before invasive operation in patients with cirrhosis associated thrombocytopenia

Retrospective analysis of cut-off value of platelet intervention before invasive operation in patients with cirrhosis associated thrombocytopenia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045372
Enrollment
Unknown
Registered
2021-04-13
Start date
2021-04-12
Completion date
Unknown
Last updated
2021-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis associated thrombocytopenia

Interventions

case series:no

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. From January 1, 2018 to December 31, 2019, all adult cirrhotic patients with thrombocytopenia who had undergone invasive procedures; 2. Diagnosis of liver cirrhosis or liver cirrhosis related liver cancer based on clinical manifestations, liver function examination, abdominal ultrasound, CT scan or histological evidence (if necessary); 3. Based on blood routine test, platelet count before invasive operation was less than 100x10^9 / L.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumors, except hepatocellular carcinoma; 2. Incomplete medical records; 3. Anticoagulant or antiplatelet drugs were given 7 days before invasive operation; 4. He has suffered from hematological diseases in the past; 5. Acute bleeding occurred 5 days before invasive operation; 6. Drug induced thrombocytopenia; 7. People infected with HIV.

Design outcomes

Primary

MeasureTime frame
Platelet count;

Countries

China

Contacts

Public ContactDing Huiguo

Beijing Youan Hospital, Capital Medical University

dinghuiguo@ccmu.edu.cn+86 13911683832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026